18-F-L 3,4-Dihydroxyphenylalanine PET/Computed Tomography in the Management of Congenital Hyperinsulinism

被引:10
作者
States, Lisa J. [1 ,2 ]
Saade-Lemus, Sandra [1 ,3 ]
De Leon, Diva D. [2 ,4 ]
机构
[1] Childrens Hosp Philadelphia, Radiol Dept, Sect Oncol Imaging, 3401 Civ Ctr Blvd, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA
[3] Roberts Ctr Pediat Res, Room 8255,2715 South St, Philadelphia, PA 19146 USA
[4] Childrens Hosp Philadelphia, Congenital Hyperinsulinism Ctr, Div Endocrinol & Diabet, 3500 Civ Ctr Blvd, Philadelphia, PA 19104 USA
关键词
Congenital hyperinsulinism; Hyperinsulinism; F-DOPA; 18F]-FDOPA; Persistent hypoglycemia; POSITRON-EMISSION-TOMOGRAPHY; COMPUTED TOMOGRAPHY; FOCAL FORM; DIAGNOSIS; INFANCY; HYPOGLYCEMIA; ACCURACY; PET/CT; SCAN; PREMEDICATION;
D O I
10.1016/j.cpet.2020.03.004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Congenital hyperinsulinism (HI) is the most common cause of persistent hypoglycemia in neonates and infants. Several genetic mutations have been identified and are associated with 2 distinct histopathologic forms of disease: diffuse and focal. Targeted clinical evaluation to distinguish medically treatable disease from disease requiring surgical management can prevent life-threatening complications. Detection and localization of a surgically curable focal lesion using PET imaging with 18-F-L 3,4-dihydroxyphenylalanine ([18F]-FDOPA) has become standard of care. This article provides guidelines for the selection of patients who can benefit from [18F]-FDOPA-PET/computed tomography and protocols and tips used to diagnose a focal lesion of HI. © 2020 Elsevier Inc.
引用
收藏
页码:349 / 359
页数:11
相关论文
共 39 条
  • [1] Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children
    Adzick, N. Scott
    De Leon, Diva D.
    States, Lisa J.
    Lord, Katherine
    Bhatti, Tricia R.
    Becker, Susan A.
    Stanley, Charles A.
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2019, 54 (01) : 27 - 32
  • [2] Multidisciplinary approach to the focal form of congenital hyperinsulinism leads to successful treatment by partial pancreatectomy
    Adzick, NS
    Thornton, PS
    Stanley, CA
    Kaye, RD
    Ruchelli, E
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2004, 39 (03) : 270 - 274
  • [3] [Anonymous], 2019, J NUCL MED, V60, p7N, DOI [10.2967/jnumed.118.219386, DOI 10.2967/JNUMED.118.219386]
  • [4] Congenital hyperinsulinism
    Arnoux, Jean-Baptiste
    de Lonlay, Pascale
    Ribeiro, Maria-Joao
    Hussain, Khalid
    Blankenstein, Oliver
    Mohnike, Klaus
    Valayannopoulos, Vassili
    Robert, Jean-Jacques
    Rahier, Jacques
    Sempoux, Christine
    Bellanne, Christine
    Verkarre, Virginie
    Aigrain, Yves
    Jaubert, Francis
    Brunelle, Francis
    Nihoul-Fekete, Claire
    [J]. EARLY HUMAN DEVELOPMENT, 2010, 86 (05) : 287 - 294
  • [5] Evaluation of [18F]Fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism
    Barthlen, Winfried
    Blankenstein, Oliver
    Mau, Harald
    Koch, Martin
    Hoehne, Claudia
    Mohnike, Wolfgang
    Eberhard, Traugott
    Fuechtner, Frank
    Lorenz-Depiereux, Bettina
    Mohnike, Klaus
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (03) : 869 - 875
  • [6] Value of 18F-fluoro-L-dopa PET in the Preoperative Localization of Focal Lesions in Congenital Hyperinsulinism
    Capito, Carmen
    Khen-Dunlop, Naziha
    Ribeiro, Maria-Joao
    Brunelle, Francis
    Aigrain, Yves
    Cretolle, Celia
    Jaubert, Francis
    De Lonlay, Pascale
    Nihoul-Fekete, Claire
    [J]. RADIOLOGY, 2009, 253 (01) : 216 - 222
  • [7] Center for Drug Evaluation and Research US Food and Drug Administration, 2019, NEW DRUG APPL APPR L
  • [8] Congenital Hypoglycemia Disorders: New Aspects of Etiology, Diagnosis, Treatment and Outcomes
    De Leon, Diva D.
    Stanley, Charles A.
    [J]. PEDIATRIC DIABETES, 2017, 18 (01) : 3 - 9
  • [9] Congenital hyperinsulinism:: Pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion
    de Lonlay, P
    Simon-Carre, A
    Ribeiro, MJ
    Boddaert, N
    Giurgea, I
    Laborde, K
    Bellanné-Chantelot, C
    Verkarre, V
    Polak, M
    Rahier, J
    Syrota, A
    Seidenwurm, D
    Nihoul-Fékété, C
    Robert, JJ
    Brunelle, F
    Jaubert, F
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) : 933 - 940
  • [10] Dhawan V, 1996, J NUCL MED, V37, P1850